Naringin
The bitter-tasting glycoside in grapefruit that your gut converts into naringenin, and the compound behind grapefruit's well-known drug interactions.
Also known as Naringoside
What it does
Flavanone glycoside, CYP3A4 modulator
Naringin is the glycoside form of naringenin, present at high concentrations in grapefruit (particularly the pith and membranes) where it is responsible for the fruit's characteristic bitterness. It is distinct from the aglycone naringenin: naringin must be hydrolysed by gut bacteria before it is absorbed, and it is naringin (together with related furanocoumarins) that gives grapefruit its clinically important interaction with several prescription medicines via inhibition of intestinal CYP3A4.
Pathways it supports
These are the ways this compound is linked to the body, strongest link first.
- Reduces Oxidative StressHelps reduce harmful oxidative damage in the body.Moderate link
- Supports Healthy Cholesterol MetabolismSupports the body's everyday cholesterol balance as part of a heart-healthy diet.Modest link
Foods that contain it
1 foods are linked to Naringin. These 1 are the best sources in the data.
- Grapefruit (opens in a new tab)FruitVery strong
The bar shows how good a source each food is in the curated data. Amounts vary with the variety, growing conditions and how the food is prepared.
Evidence and sources
Research strength: Moderate. The rating draws on NHS.
What the sources are: 2 sources studied people (2 randomised trials); 2 are background reviews that explain the science; 1 other source.
- Review of grapefruit juice-drugs interactions mediated by intestinal CYP3A4 inhibition (naringin and furanocoumarins) (opens in a new tab)Journal of Applied Pharmaceutical Science, 2024Review article
- Naringin reduces body weight, plasma lipids and increases adiponectin levels in patients with dyslipidemia (opens in a new tab)International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 2022Randomised trialDOI (opens in a new tab)
- High-dose short-term administration of naringin did not alter talinolol pharmacokinetics in humans (opens in a new tab)European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2015Randomised trialDOI (opens in a new tab)
- Endothelial and Cardiovascular Effects of Naringin: A Systematic Review (opens in a new tab)Nutrients, 2025Systematic reviewDOI (opens in a new tab)
- Phytochemical Properties, Extraction, and Pharmacological Benefits of Naringin: A Review (opens in a new tab)Molecules (Basel, Switzerland), 2023Review articleDOI (opens in a new tab)
Source links last checked on 1 November 2026.
This page is general information about food and wellbeing. It is not medical advice and does not replace advice from your doctor or dietitian.